Pulmatrix, Inc is a biotechnology business based in the US. Pulmatrix shares (PULM) are listed on the NASDAQ and all prices are listed in US Dollars. Pulmatrix employs 20 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Pulmatrix
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – PULM – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Pulmatrix stock price (NASDAQ: PULM)Use our graph to track the performance of PULM stocks over time.
Pulmatrix shares at a glance
|Latest market close||$0.93|
|52-week range||$0.82 - $2.21|
|50-day moving average||$0.99|
|200-day moving average||$1.23|
|Wall St. target price||$5.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-2.47|
Buy Pulmatrix shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Pulmatrix stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Pulmatrix price performance over time
|1 week (2021-07-19)||N/A|
|1 month (2021-06-30)||-10.48%|
|3 months (2021-04-30)||-2.00%|
|6 months (2021-01-26)||N/A|
|1 year (2020-07-26)||N/A|
|2 years (2019-07-26)||N/A|
|3 years (2018-07-26)||N/A|
|5 years (2016-07-26)||N/A|
|Revenue TTM||$11.3 million|
|Gross profit TTM||$-2,975,000|
|Return on assets TTM||-11.44%|
|Return on equity TTM||-58.9%|
|Market capitalisation||$50.5 million|
TTM: trailing 12 months
Shorting Pulmatrix shares
There are currently 737,633 Pulmatrix shares held short by investors – that's known as Pulmatrix's "short interest". This figure is 2.1% down from 753,350 last month.
There are a few different ways that this level of interest in shorting Pulmatrix shares can be evaluated.
Pulmatrix's "short interest ratio" (SIR)
Pulmatrix's "short interest ratio" (SIR) is the quantity of Pulmatrix shares currently shorted divided by the average quantity of Pulmatrix shares traded daily (recently around 619859.66386555). Pulmatrix's SIR currently stands at 1.19. In other words for every 100,000 Pulmatrix shares traded daily on the market, roughly 1190 shares are currently held short.
However Pulmatrix's short interest can also be evaluated against the total number of Pulmatrix shares, or, against the total number of tradable Pulmatrix shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Pulmatrix's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Pulmatrix shares in existence, roughly 10 shares are currently held short) or 0.014% of the tradable shares (for every 100,000 tradable Pulmatrix shares, roughly 14 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Pulmatrix.
Find out more about how you can short Pulmatrix stock.
Pulmatrix share dividends
We're not expecting Pulmatrix to pay a dividend over the next 12 months.
Have Pulmatrix's shares ever split?
Pulmatrix's shares were split on a 1:10 basis on 5 February 2019. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Pulmatrix shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Pulmatrix shares which in turn could have impacted Pulmatrix's share price.
Pulmatrix share price volatility
Over the last 12 months, Pulmatrix's shares have ranged in value from as little as $0.82 up to $2.21. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Pulmatrix's is 1.3841. This would suggest that Pulmatrix's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Pulmatrix, Inc. , a clinical stage biopharmaceutical company, discovers and develops inhaled therapies to prevent and treat respiratory and other diseases with unmet medical needs in the United States. The company focuses on developing products based on its inhaled Small Particles Easily Respirable and Emitted (iSPERSE) technology, which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. It engages in developing Pulmazole, an inhaled anti-fungal drug that is in Phase 2b clinical trials for the prevention and treatment of fungal infections and allergic/hypersensitivity reactions to fungus in patients with severe lung diseases comprising asthma, cystic fibrosis, and allergic bronchopulmonary aspergillosis; PUR1800, a narrow spectrum kinase inhibitor that is in Phase 1b clinical trials for patients with lung cancer and chronic obstructive pulmonary disease; and PUR3100, an iSPERSE formulation of dihydroergotamine for the treatment of acute migraine. The company has a license agreement with RespiVert Ltd. for access to a portfolio of kinase inhibitor drug candidates; a development and commercialization agreement with Cipla Technologies LLC for the development and commercialization of Pulmazole; and a collaboration and license agreement with Sensory Cloud, Inc. Pulmatrix, Inc.
Stocks similar to Pulmatrix
Pulmatrix in the news
Pulmatrix appoints Director Anand Varadan
Pulmatrix appoints Director Anand Varadan
Pulmatrix appoints Anand Vardan to board of directors
Frequently asked questionsWhat percentage of Pulmatrix is owned by insiders or institutions?
Currently 0.058% of Pulmatrix shares are held by insiders and 22.8% by institutions. How many people work for Pulmatrix?
Latest data suggests 20 work at Pulmatrix. When does the fiscal year end for Pulmatrix?
Pulmatrix's fiscal year ends in December. Where is Pulmatrix based?
Pulmatrix's address is: 99 Hayden Avenue, Lexington, MA, United States, 02421 What is Pulmatrix's ISIN number?
Pulmatrix's international securities identification number is: US74584P2020 What is Pulmatrix's CUSIP number?
Pulmatrix's Committee on Uniform Securities Identification Procedures number is: 74584P103
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert